Think the results of your last Joint Commission survey were hard to understand? If CMS has their way, it may get murkier.

The blood test, Called PanSeer, detected cancer in 91% of people who had been asymptomatic when the samples were collected and were diagnosed with cancer one to four years later.

The prevalence of antibodies for people recovering from a mild cases of COVID-19 dropped precipitously after less than three months, according to a research letter published this week in The New England Journal of Medicine.

New research has linked several factors with risk of death in critically ill patients with coronavirus disease 2019 (COVID-19).

The cost of poor medication adherence is tremendous—nearly $177 billion each year in direct and indirect healthcare costs—but the cost of nonadherence during the COVID-19 pandemic has the potential to be much higher. Medication nonadherence can drive up otherwise avoidable hospital admissions, burdening healthcare systems already struggling to care for coronavirus patients and putting other patients at greater risk of contracting COVID-19.

Kevin Ann Huckshorn, PhD, MSN, RN, CADC, ICRC, a national behavioral health consultant with years of experience in hospital settings and now the director of evidence-based practices and programs for Wellpath Recovery Solutions, spoke to Patient Safety Monitor Journal on how to keep your policy up to date.

Compared with patients hospitalized in urban areas, however, the study found that the risk of death was about 5% higher for patients hospitalized in large towns (with populations of 250,000 to 1 million people), 10% higher for patients in small towns (with populations of 50,000 to 250,000), 16% higher for patients in rural areas (with populations of 10,000 to 50,000) and 21% higher for patients in remote rural areas (with populations of less than 10,000).

The projected shortage of physicians is worsening. Last year, the AAMC projected the shortfall of physicians at as many as 122,000 by 2032. The new report released today projects the shortfall at as many as 139,000 physicians by 2033.

The following Q&A resulted from a conversation PSQH had with Tom Knight, CEO of Georgia-based Invistics, a provider of cloud-based software solutions that improve healthcare inventory visibility and analytics across complex healthcare systems and global supply chains. Invistics commissioned a study by Porter Research revealing that while nearly all healthcare professionals agree that drug diversion is occurring across the country, two out of five hospitals still do not have effective drug diversion prevention programs in place.